Categories: Latest

Envigo collaboration with OCSiAl and Intertek results in single wall carbon nanotubes completing REACH registration for the first time ever

New Delhi, October 15, 2016: Envigo is pleased to announce the successful outcome of its industry collaboration with Intertek and OCSiAl to meet the latter’s regulatory requirements for its core product: TUBALL™ single wall carbon nanotubes. As a result of the collaboration, OCSiAl has opened a new substance in the EU’s Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation under the number 01-2120130006-75-0000. This registration proves that TUBALL™ single wall carbon nanotubes fully comply with REACH regulations. OCSiAl is the world’s first manufacturer of single wall carbon nanotubes (SWCNT) to complete REACH registration, taking the lead in raising the visibility of nanotube management worldwide and boosting its applications in a wide range of industries.

Over the course of six months, scientists at OCSiAl, Envigo and Intertek collaborated to conduct extensive research and testing on potentially hazardous properties of SWCNT. These efforts resulted in a technical and highly detailed analysis of SWCNT, their nature and potential risks, as well as in specifications on particular methods of risk management. This in-depth information will support the expansion of mass applications of SWCNT in various industries, including consumable products.

OCSiAl is the only company in the market that is capable of producing industrial-scale volumes of single wall carbon nanotubes. With its REACH registration, OCSiAl currently commercializes 10 tonnes of single wall carbon nanotubes in Europe. OCSiAl’s global production capacity of TUBALL™ will reach 60 tonnes next year. REACH registration will support OCSiAl’s drive to further scale up its nanotube manufacturing volumes and boost the company’s presence in the European market.

Adrian Hardy, Chief Executive Officer of Envigo, comments about the successful registration of OCSiAl’s product: “It’s very exciting for Envigo to be a partner in fostering important innovation – in this instance bringing our skills, expertise and comprehensive REACH testing capabilities to help OCSiAl meet all of the REACH requirements for its TUBALL™ product. We are therefore delighted to have worked closely with Intertek and OCSiAl to enable the REACH registration of single wall carbon nanotubes – an industry first.”

According to OCSiAl’s EHS Lead Manager, Gunther Van Kerckhove, “OCSiAl shares REACH’s goals and considers the completion of mandatory registration as one of the milestones in the company’s goal to provide the European market and global community with a more comprehensive understanding of nanotubes, their nature, safety, and potential for use in a wide range of industries and products.”

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Venus Remedies partners with NSDC to pioneer workforce development through skill certification

Initiative aimed at enhancing workforce skills and competency in line with industry standards so as…

7 hours ago

80-Year-Old Diabetic Patient’s second leg Saved at Apex Group of Hospitals, Borivali

Previously, the patient underwent an above-knee amputation in the USA due to similar complications in the…

7 hours ago

Miraculous Recovery: 23-weeker Micro-Preemie Thrives After 100 Days in NICU at Motherhood Hospitals, Kharghar

New Delhi, December 27, 2024: A team of expert obstetricians & neonatologists at Motherhood Hospitals,…

7 hours ago

Diabetes Myths vs. Facts: Clearing Up Common Misconceptions

By  Dr. Khushali Lalcheta, Consultant Physician, HCG Hospitals, Rajkot Diabetes is often a misunderstood condition that…

7 hours ago

Foreign Accent Syndrome: 6 Major Causes and Symptoms

By Dr. Balaji B S, Consultant - Neurology & Epileptology, Aster Whitefield Hospital, Bengaluru Foreign…

7 hours ago

Aakash Healthcare Partners with Japan for Groundbreaking Surgical Intervention: A Global Collaboration to Revolutionize Cardiovascular Care

New Delhi, December 27, 2024: Aakash Healthcare Super Specialty Hospital, New Delhi, has taken a…

7 hours ago